Đang chuẩn bị liên kết để tải về tài liệu:
Blood parameters of horses maintained over pasture under temperate climatic conditions in Kashmir

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Haematological parameters in ten apparently healthy adult horses at Mountain research Centre for Sheep and Goat, SKUAST Kashmir were examined to establish their reference values. The mean red blood cell (RBC) counts, packed cell volume (PCV), haemoglobin (Hb) concentration, white blood cell (WBC) counts, mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH) and mean corpuscular haemoglobin concentration (MCHC) were found to be comparable with the normal values. The mean absolute values of neutrophil, eosinophil, lymphocyte, monocyte and basophil were also within the normal range. | Nội dung Text Blood parameters of horses maintained over pasture under temperate climatic conditions in Kashmir

TÀI LIỆU LIÊN QUAN

Effect of watering frequencies and rehydration on blood parameters of indigenous sheep

Blood parameters of horses maintained over pasture under temperate climatic conditions in Kashmir

The chronic effects of Teucrium polium on some blood parameters and histopathology of liver and kidney in the rat

Impact of water deprivation and rehydration on blood parameters of sheep under middle gujarat agro-climatic condition

Effect of using aloe vera (Aloe barbadensis) and neem (Azadirachta indica) leaves powder on blood biochemical parameters in vanraja poultry birds

Using arterial blood as a substitute for venous blood in routine biochemistry parameter examinations in rabbits

Effect of dietary REE supplementation on blood biochemical parameters in layer chicken

Effect of supplementation of herbs containing essential oils on nutrients digestibility, rumen fermentation and blood parameters in cross bred calves

Effect of dietary tryptophan supplementation on blood biochemical parameters in layer chicken

Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab